Primary information |
---|
CancerPPD ID | 1841 |
PMID | None |
YEAR | 2005 |
SEQUENCE | GIGAVLKVLTTGLPALISWIKRKRQQ |
LENGTH | 26 |
NAME | MELITTIIN |
C-ter Modification | Amidation |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | L |
Non-Natural | None |
NATURE | Anticancer |
ACTIVITY | LD50 =9 µg/ml |
SOURCE | FLAK peptides |
Cancer Type | Breast Cancer |
ASSAY | MTT/MTS assay |
Patent ID | US_06875744_B2 |
Tissue | Breast |
CELL LINE | MCF-7 |
TEST TIME | 24-h |
Secondary information |
---|
STRUCTURE | |
DSSP states | CCTTHHHHSSSSCTTHHHHHHHHHCC |
SMILES | [NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | NA | NA | NA | NA | NA | NA | NA |
|